Global Biochips Market 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	156 Pages	TechNavio	April, 2023	INF17920622

Best Price Guarantee
Price	from $2,500
Length	156 Pages
Publisher	TechNavio
Published Date	April, 2023
SKU	INF17920622

Global Biochips Market 2023-2027

Technavio has been monitoring the biochips market and is forecast to grow by USD 43,273.01 mn during 2022-2027, accelerating at a CAGR of 25.15% during the forecast period. Our report on the biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing applications of microarray biochips in drug discovery, an increase in the market presence of market players with a collaboration strategy, and the growing use of personalized medicines.
Technavio's biochips market is segmented as below:

By End-user

Biotechnology and pharmaceutical companies
Hospitals and diagnostics centers
Academic and research institutes

By Technology

Microarrays
Microfluidics

By Geographical Landscape

North America
Europe
APAC
Middle East and Africa
South America

This study identifies the increasing use of chemical microarray technology as one of the prime reasons driving the biochips market growth during the next few years. Also, emerging loc technology and growth in the bioinformatics software industry will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the biochips market covers the following areas:

Biochips market sizing
Biochips market forecast
Biochips market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biochips market vendors that include Agilent Technologies Inc., Analis sa, Arrayit Corp., BICO Group AB, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., Dynamic Biosensors GmbH, Eden Tech, Greiner Bio-One International GmbH, Illumina Inc., INNOPSYS, Micronit BV, Nutcracker Therapeutics Inc., Perkin Elmer Inc., QIAGEN NV, Randox Laboratories Ltd., Sphere Fluidics Ltd., Takara Holdings Inc., IDEX Corp., and Thermo Fisher Scientific Inc.. Also, the biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 Global biochips market 2017 - 2021; Exhibit 18: Historic Market Size - Data Table on Global biochips market 2017 - 2021 ($ million); 4.2 By End-user Segment Analysis 2017 - 2021; Exhibit 19: Historic Market Size - By End-user Segment 2017 - 2021 ($ million); 4.3 By Technology Segment Analysis 2017 - 2021; Exhibit 20: Historic Market Size - By Technology Segment 2017 - 2021 ($ million); 4.4 Geography Segment Analysis 2017 - 2021; Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); 4.5 Country Segment Analysis 2017 - 2021; Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2022-2027 (%); Exhibit 31: Data Table on End-user - Market share 2022-2027 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027; Exhibit 34: Chart on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibit 35: Data Table on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibit 36: Chart on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%); Exhibit 37: Data Table on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%); 6.4 Hospitals and diagnostics centers - Market size and forecast 2022-2027; Exhibit 38: Chart on Hospitals and diagnostics centers - Market size and forecast 2022-2027 ($ million); Exhibit 39: Data Table on Hospitals and diagnostics centers - Market size and forecast 2022-2027 ($ million); Exhibit 40: Chart on Hospitals and diagnostics centers - Year-over-year growth 2022-2027 (%); Exhibit 41: Data Table on Hospitals and diagnostics centers - Year-over-year growth 2022-2027 (%); 6.5 Academic and research institutes - Market size and forecast 2022-2027; Exhibit 42: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million); Exhibit 43: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million); Exhibit 44: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%); Exhibit 45: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ million); Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Technology: 7.1 Market segments; Exhibit 48: Chart on Technology - Market share 2022-2027 (%); Exhibit 49: Data Table on Technology - Market share 2022-2027 (%); 7.2 Comparison by Technology; Exhibit 50: Chart on Comparison by Technology; Exhibit 51: Data Table on Comparison by Technology; 7.3 Microarrays - Market size and forecast 2022-2027; Exhibit 52: Chart on Microarrays - Market size and forecast 2022-2027 ($ million); Exhibit 53: Data Table on Microarrays - Market size and forecast 2022-2027 ($ million); Exhibit 54: Chart on Microarrays - Year-over-year growth 2022-2027 (%); Exhibit 55: Data Table on Microarrays - Year-over-year growth 2022-2027 (%); 7.4 Microfluidics - Market size and forecast 2022-2027; Exhibit 56: Chart on Microfluidics - Market size and forecast 2022-2027 ($ million); Exhibit 57: Data Table on Microfluidics - Market size and forecast 2022-2027 ($ million); Exhibit 58: Chart on Microfluidics - Year-over-year growth 2022-2027 (%); Exhibit 59: Data Table on Microfluidics - Year-over-year growth 2022-2027 (%); 7.5 Market opportunity by Technology; Exhibit 60: Market opportunity by Technology ($ million); Exhibit 61: Data Table on Market opportunity by Technology ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%); 9.2 Geographic comparison; Exhibit 65: Chart on Geographic comparison; Exhibit 66: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2022-2027; Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%); 9.4 Europe - Market size and forecast 2022-2027; Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%); 9.5 APAC - Market size and forecast 2022-2027; Exhibit 75: Chart on APAC - Market size and forecast 2022-2027 ($ million); Exhibit 76: Data Table on APAC - Market size and forecast 2022-2027 ($ million); Exhibit 77: Chart on APAC - Year-over-year growth 2022-2027 (%); Exhibit 78: Data Table on APAC - Year-over-year growth 2022-2027 (%); 9.6 Middle East and Africa - Market size and forecast 2022-2027; Exhibit 79: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million); Exhibit 80: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million); Exhibit 81: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%); Exhibit 82: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%); 9.7 South America - Market size and forecast 2022-2027; Exhibit 83: Chart on South America - Market size and forecast 2022-2027 ($ million); Exhibit 84: Data Table on South America - Market size and forecast 2022-2027 ($ million); Exhibit 85: Chart on South America - Year-over-year growth 2022-2027 (%); Exhibit 86: Data Table on South America - Year-over-year growth 2022-2027 (%); 9.8 US - Market size and forecast 2022-2027; Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%); Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%); 9.9 China - Market size and forecast 2022-2027; Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%); Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%); 9.10 Russia - Market size and forecast 2022-2027; Exhibit 95: Chart on Russia - Market size and forecast 2022-2027 ($ million); Exhibit 96: Data Table on Russia - Market size and forecast 2022-2027 ($ million); Exhibit 97: Chart on Russia - Year-over-year growth 2022-2027 (%); Exhibit 98: Data Table on Russia - Year-over-year growth 2022-2027 (%); 9.11 UK - Market size and forecast 2022-2027; Exhibit 99: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibit 100: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibit 101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 102: Data Table on UK - Year-over-year growth 2022-2027 (%); 9.12 France - Market size and forecast 2022-2027; Exhibit 103: Chart on France - Market size and forecast 2022-2027 ($ million); Exhibit 104: Data Table on France - Market size and forecast 2022-2027 ($ million); Exhibit 105: Chart on France - Year-over-year growth 2022-2027 (%); Exhibit 106: Data Table on France - Year-over-year growth 2022-2027 (%); 9.13 Market opportunity By Geographical Landscape; Exhibit 107: Market opportunity By Geographical Landscape ($ million); Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 109: Impact of drivers and challenges in 2022 and 2027; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 110: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 111: Overview on factors of disruption; 11.4 Industry risks; Exhibit 112: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 113: Vendors covered; 12.2 Market positioning of vendors; Exhibit 114: Matrix on vendor position and classification; 12.3 Agilent Technologies Inc.; Exhibit 115: Agilent Technologies Inc. - Overview; Exhibit 116: Agilent Technologies Inc. - Business segments; Exhibit 117: Agilent Technologies Inc. - Key offerings; Exhibit 118: Agilent Technologies Inc. - Segment focus; 12.4 Arrayit Corp.; Exhibit 119: Arrayit Corp. - Overview; Exhibit 120: Arrayit Corp. - Product / Service; Exhibit 121: Arrayit Corp. - Key offerings; 12.5 BICO Group AB; Exhibit 122: BICO Group AB - Overview; Exhibit 123: BICO Group AB - Business segments; Exhibit 124: BICO Group AB - Key offerings; Exhibit 125: BICO Group AB - Segment focus; 12.6 Bio Rad Laboratories Inc.; Exhibit 126: Bio Rad Laboratories Inc. - Overview; Exhibit 127: Bio Rad Laboratories Inc. - Business segments; Exhibit 128: Bio Rad Laboratories Inc. - Key news; Exhibit 129: Bio Rad Laboratories Inc. - Key offerings; Exhibit 130: Bio Rad Laboratories Inc. - Segment focus; 12.7 Boao Bio Group Co. Ltd.; Exhibit 131: Boao Bio Group Co. Ltd. - Overview; Exhibit 132: Boao Bio Group Co. Ltd. - Product / Service; Exhibit 133: Boao Bio Group Co. Ltd. - Key offerings; 12.8 Eden Tech; Exhibit 134: Eden Tech - Overview; Exhibit 135: Eden Tech - Product / Service; Exhibit 136: Eden Tech - Key offerings; 12.9 Greiner Bio One International GmbH; Exhibit 137: Greiner Bio One International GmbH - Overview; Exhibit 138: Greiner Bio One International GmbH - Product / Service; Exhibit 139: Greiner Bio One International GmbH - Key offerings; 12.10 Illumina Inc.; Exhibit 140: Illumina Inc. - Overview; Exhibit 141: Illumina Inc. - Business segments; Exhibit 142: Illumina Inc. - Key news; Exhibit 143: Illumina Inc. - Key offerings; Exhibit 144: Illumina Inc. - Segment focus; 12.11 INNOPSYS; Exhibit 145: INNOPSYS - Overview; Exhibit 146: INNOPSYS - Product / Service; Exhibit 147: INNOPSYS - Key offerings; 12.12 Nutcracker Therapeutics Inc.; Exhibit 148: Nutcracker Therapeutics Inc. - Overview; Exhibit 149: Nutcracker Therapeutics Inc. - Product / Service; Exhibit 150: Nutcracker Therapeutics Inc. - Key offerings; 12.13 Perkin Elmer Inc.; Exhibit 151: Perkin Elmer Inc. - Overview; Exhibit 152: Perkin Elmer Inc. - Business segments; Exhibit 153: Perkin Elmer Inc. - Key news; Exhibit 154: Perkin Elmer Inc. - Key offerings; Exhibit 155: Perkin Elmer Inc. - Segment focus; 12.14 QIAGEN NV; Exhibit 156: QIAGEN NV - Overview; Exhibit 157: QIAGEN NV - Product / Service; Exhibit 158: QIAGEN NV - Key news; Exhibit 159: QIAGEN NV - Key offerings; 12.15 Sphere Fluidics Ltd.; Exhibit 160: Sphere Fluidics Ltd. - Overview; Exhibit 161: Sphere Fluidics Ltd. - Product / Service; Exhibit 162: Sphere Fluidics Ltd. - Key offerings; 12.16 Takara Holdings Inc.; Exhibit 163: Takara Holdings Inc. - Overview; Exhibit 164: Takara Holdings Inc. - Business segments; Exhibit 165: Takara Holdings Inc. - Key offerings; Exhibit 166: Takara Holdings Inc. - Segment focus; 12.17 Thermo Fisher Scientific Inc.; Exhibit 167: Thermo Fisher Scientific Inc. - Overview; Exhibit 168: Thermo Fisher Scientific Inc. - Business segments; Exhibit 169: Thermo Fisher Scientific Inc. - Key news; Exhibit 170: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 171: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 172: Inclusions checklist; Exhibit 173: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 174: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 175: Research methodology; Exhibit 176: Validation techniques employed for market sizing; Exhibit 177: Information sources; 13.5 List of abbreviations; Exhibit 178: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Technology; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%); Exhibits18: Historic Market Size - Data Table on Global biochips market 2017 - 2021 ($ million); Exhibits19: Historic Market Size - By End-user Segment 2017 - 2021 ($ million); Exhibits20: Historic Market Size - By Technology Segment 2017 - 2021 ($ million); Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million); Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million); Exhibits23: Five forces analysis - Comparison between 2022 and 2027; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits29: Chart on Market condition - Five forces 2022 and 2027; Exhibits30: Chart on End-user - Market share 2022-2027 (%); Exhibits31: Data Table on End-user - Market share 2022-2027 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibits35: Data Table on Biotechnology and pharmaceutical companies - Market size and forecast 2022-2027 ($ million); Exhibits36: Chart on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%); Exhibits37: Data Table on Biotechnology and pharmaceutical companies - Year-over-year growth 2022-2027 (%); Exhibits38: Chart on Hospitals and diagnostics centers - Market size and forecast 2022-2027 ($ million); Exhibits39: Data Table on Hospitals and diagnostics centers - Market size and forecast 2022-2027 ($ million); Exhibits40: Chart on Hospitals and diagnostics centers - Year-over-year growth 2022-2027 (%); Exhibits41: Data Table on Hospitals and diagnostics centers - Year-over-year growth 2022-2027 (%); Exhibits42: Chart on Academic and research institutes - Market size and forecast 2022-2027 ($ million); Exhibits43: Data Table on Academic and research institutes - Market size and forecast 2022-2027 ($ million); Exhibits44: Chart on Academic and research institutes - Year-over-year growth 2022-2027 (%); Exhibits45: Data Table on Academic and research institutes - Year-over-year growth 2022-2027 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Chart on Technology - Market share 2022-2027 (%); Exhibits49: Data Table on Technology - Market share 2022-2027 (%); Exhibits50: Chart on Comparison by Technology; Exhibits51: Data Table on Comparison by Technology; Exhibits52: Chart on Microarrays - Market size and forecast 2022-2027 ($ million); Exhibits53: Data Table on Microarrays - Market size and forecast 2022-2027 ($ million); Exhibits54: Chart on Microarrays - Year-over-year growth 2022-2027 (%); Exhibits55: Data Table on Microarrays - Year-over-year growth 2022-2027 (%); Exhibits56: Chart on Microfluidics - Market size and forecast 2022-2027 ($ million); Exhibits57: Data Table on Microfluidics - Market size and forecast 2022-2027 ($ million); Exhibits58: Chart on Microfluidics - Year-over-year growth 2022-2027 (%); Exhibits59: Data Table on Microfluidics - Year-over-year growth 2022-2027 (%); Exhibits60: Market opportunity by Technology ($ million); Exhibits61: Data Table on Market opportunity by Technology ($ million); Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits63: Chart on Market share By Geographical Landscape 2022-2027 (%); Exhibits64: Data Table on Market share By Geographical Landscape 2022-2027 (%); Exhibits65: Chart on Geographic comparison; Exhibits66: Data Table on Geographic comparison; Exhibits67: Chart on North America - Market size and forecast 2022-2027 ($ million); Exhibits68: Data Table on North America - Market size and forecast 2022-2027 ($ million); Exhibits69: Chart on North America - Year-over-year growth 2022-2027 (%); Exhibits70: Data Table on North America - Year-over-year growth 2022-2027 (%); Exhibits71: Chart on Europe - Market size and forecast 2022-2027 ($ million); Exhibits72: Data Table on Europe - Market size and forecast 2022-2027 ($ million); Exhibits73: Chart on Europe - Year-over-year growth 2022-2027 (%); Exhibits74: Data Table on Europe - Year-over-year growth 2022-2027 (%); Exhibits75: Chart on APAC - Market size and forecast 2022-2027 ($ million); Exhibits76: Data Table on APAC - Market size and forecast 2022-2027 ($ million); Exhibits77: Chart on APAC - Year-over-year growth 2022-2027 (%); Exhibits78: Data Table on APAC - Year-over-year growth 2022-2027 (%); Exhibits79: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million); Exhibits80: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million); Exhibits81: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%); Exhibits82: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%); Exhibits83: Chart on South America - Market size and forecast 2022-2027 ($ million); Exhibits84: Data Table on South America - Market size and forecast 2022-2027 ($ million); Exhibits85: Chart on South America - Year-over-year growth 2022-2027 (%); Exhibits86: Data Table on South America - Year-over-year growth 2022-2027 (%); Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million); Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million); Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%); Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%); Exhibits91: Chart on China - Market size and forecast 2022-2027 ($ million); Exhibits92: Data Table on China - Market size and forecast 2022-2027 ($ million); Exhibits93: Chart on China - Year-over-year growth 2022-2027 (%); Exhibits94: Data Table on China - Year-over-year growth 2022-2027 (%); Exhibits95: Chart on Russia - Market size and forecast 2022-2027 ($ million); Exhibits96: Data Table on Russia - Market size and forecast 2022-2027 ($ million); Exhibits97: Chart on Russia - Year-over-year growth 2022-2027 (%); Exhibits98: Data Table on Russia - Year-over-year growth 2022-2027 (%); Exhibits99: Chart on UK - Market size and forecast 2022-2027 ($ million); Exhibits100: Data Table on UK - Market size and forecast 2022-2027 ($ million); Exhibits101: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits102: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits103: Chart on France - Market size and forecast 2022-2027 ($ million); Exhibits104: Data Table on France - Market size and forecast 2022-2027 ($ million); Exhibits105: Chart on France - Year-over-year growth 2022-2027 (%); Exhibits106: Data Table on France - Year-over-year growth 2022-2027 (%); Exhibits107: Market opportunity By Geographical Landscape ($ million); Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits109: Impact of drivers and challenges in 2022 and 2027; Exhibits110: Overview on Criticality of inputs and Factors of differentiation; Exhibits111: Overview on factors of disruption; Exhibits112: Impact of key risks on business; Exhibits113: Vendors covered; Exhibits114: Matrix on vendor position and classification; Exhibits115: Agilent Technologies Inc. - Overview; Exhibits116: Agilent Technologies Inc. - Business segments; Exhibits117: Agilent Technologies Inc. - Key offerings; Exhibits118: Agilent Technologies Inc. - Segment focus; Exhibits119: Arrayit Corp. - Overview; Exhibits120: Arrayit Corp. - Product / Service; Exhibits121: Arrayit Corp. - Key offerings; Exhibits122: BICO Group AB - Overview; Exhibits123: BICO Group AB - Business segments; Exhibits124: BICO Group AB - Key offerings; Exhibits125: BICO Group AB - Segment focus; Exhibits126: Bio Rad Laboratories Inc. - Overview; Exhibits127: Bio Rad Laboratories Inc. - Business segments; Exhibits128: Bio Rad Laboratories Inc. - Key news; Exhibits129: Bio Rad Laboratories Inc. - Key offerings; Exhibits130: Bio Rad Laboratories Inc. - Segment focus; Exhibits131: Boao Bio Group Co. Ltd. - Overview; Exhibits132: Boao Bio Group Co. Ltd. - Product / Service; Exhibits133: Boao Bio Group Co. Ltd. - Key offerings; Exhibits134: Eden Tech - Overview; Exhibits135: Eden Tech - Product / Service; Exhibits136: Eden Tech - Key offerings; Exhibits137: Greiner Bio One International GmbH - Overview; Exhibits138: Greiner Bio One International GmbH - Product / Service; Exhibits139: Greiner Bio One International GmbH - Key offerings; Exhibits140: Illumina Inc. - Overview; Exhibits141: Illumina Inc. - Business segments; Exhibits142: Illumina Inc. - Key news; Exhibits143: Illumina Inc. - Key offerings; Exhibits144: Illumina Inc. - Segment focus; Exhibits145: INNOPSYS - Overview; Exhibits146: INNOPSYS - Product / Service; Exhibits147: INNOPSYS - Key offerings; Exhibits148: Nutcracker Therapeutics Inc. - Overview; Exhibits149: Nutcracker Therapeutics Inc. - Product / Service; Exhibits150: Nutcracker Therapeutics Inc. - Key offerings; Exhibits151: Perkin Elmer Inc. - Overview; Exhibits152: Perkin Elmer Inc. - Business segments; Exhibits153: Perkin Elmer Inc. - Key news; Exhibits154: Perkin Elmer Inc. - Key offerings; Exhibits155: Perkin Elmer Inc. - Segment focus; Exhibits156: QIAGEN NV - Overview; Exhibits157: QIAGEN NV - Product / Service; Exhibits158: QIAGEN NV - Key news; Exhibits159: QIAGEN NV - Key offerings; Exhibits160: Sphere Fluidics Ltd. - Overview; Exhibits161: Sphere Fluidics Ltd. - Product / Service; Exhibits162: Sphere Fluidics Ltd. - Key offerings; Exhibits163: Takara Holdings Inc. - Overview; Exhibits164: Takara Holdings Inc. - Business segments; Exhibits165: Takara Holdings Inc. - Key offerings; Exhibits166: Takara Holdings Inc. - Segment focus; Exhibits167: Thermo Fisher Scientific Inc. - Overview; Exhibits168: Thermo Fisher Scientific Inc. - Business segments; Exhibits169: Thermo Fisher Scientific Inc. - Key news; Exhibits170: Thermo Fisher Scientific Inc. - Key offerings; Exhibits171: Thermo Fisher Scientific Inc. - Segment focus; Exhibits172: Inclusions checklist; Exhibits173: Exclusions checklist; Exhibits174: Currency conversion rates for US$; Exhibits175: Research methodology; Exhibits176: Validation techniques employed for market sizing; Exhibits177: Information sources; Exhibits178: List of abbreviations